ofloxacin has been researched along with imipenem, anhydrous in 94 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (7.45) | 18.7374 |
| 1990's | 27 (28.72) | 18.2507 |
| 2000's | 37 (39.36) | 29.6817 |
| 2010's | 22 (23.40) | 24.3611 |
| 2020's | 1 (1.06) | 2.80 |
| Authors | Studies |
|---|---|
| Katakami, M; Miyake, Y; Murakami, K; Ono, T; Susilowati, H; Viducic, D | 1 |
| Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
| Archer, G; Cuirolo, A; Faccone, D; Goldstein, F; Kitzis, MD; Ly, A; Morris, J; Perutka, J; Plata, K; Rosato, AE; Sournia, A | 1 |
| Bouza, E; Cercenado, E; Coll, P; Gutiérrez, O; Juan, C; Navarro, F; Oliver, A; Pérez, JL | 1 |
| Higashide, M; Ichimura, S; Kumano, M; Kuroda, M; Ohkawa, S; Ohta, T; Omura, CT | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
| Cattoir, V; Nordmann, P; Poirel, L | 1 |
| Hanaki, H; Maseda, H; Nakae, T; Sugimura, M | 1 |
| Fujimoto, S; Ike, Y; Okuzumi, K; Tanimoto, K; Tomita, H | 1 |
| Kirikae, T; Kitao, T; Miyoshi-Akiyama, T | 1 |
| Girlich, D; Nordmann, P; Poirel, L | 1 |
| Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Bera, S; Mondal, D | 1 |
| Bekker, OB; Charushin, VN; Danilenko, VN; Ignatenko, NK; Ishmetova, RI; Korotina, AV; Maslov, DA; Rusinov, GL; Shur, KV; Tolshchina, SG; Vatlin, AA | 1 |
| Blanco, C; Demay, F; Dhalluin, A; Ermel, G; Georgeault, S; Giard, JC; Gillet, R; Gomes Von Borowski, R; Hanh Le, H; Jean, M; Radigue, R; Thepaut, M; Trautwetter, A; Tresse, C; van de Weghe, P | 1 |
| Haider, F; Orfila, J | 1 |
| Hondou, T; Sugase, M; Yajima, H | 1 |
| Beaucaire, G; Beuscart, C; Caillaux, M; Chidiac, C; Karp, P; Leroy, O | 1 |
| Baetz, R; Borner, K; Lebahn, K; Lode, H; Olschewski, P; Reinke, M; Sievers, H; Wagner, J; Wiley, E; Wintermantel, M | 1 |
| Kwan, SY; Lee, J; Wong, PC; Yew, WW | 1 |
| Chin, NX; Neu, HC | 1 |
| Bauer, D; Spohr, M; Traub, WH | 1 |
| Chin, NX; Figueredo, VM; Neu, HC; Novelli, A | 1 |
| Gulden, H; Kern, W; Kurrle, E; Vanek, E | 1 |
| Chin, NX; Espinoza, AM; Neu, HC; Novelli, A | 1 |
| Neu, HC | 1 |
| Cohen, MA; Dazer, ME; Domagala, JM; Huband, MD; Meservey, MA; Roland, GE; Yoder, SL | 1 |
| Brook, I; Ledney, GD | 1 |
| Gospodarek, E | 1 |
| Asada, Y; Mitsuya, K; Namura, S; Nishijima, S | 1 |
| Bolash, NK; Liu, HH; Lynch, RA; McAnany, ME | 1 |
| Hecht, DW; Osmolski, JR | 1 |
| Hanberger, H; Nilsson, LE; Svensson, E | 1 |
| Flynn, CM; Johnson, DM; Jones, RN | 1 |
| Okonogi, K; Tsuchimori, N; Yamazaki, T | 1 |
| Akama, M; Araki, H; Iyobe, S; Minami, S; Mitsuhashi, S; Narita, H; Watanabe, Y | 1 |
| Aikawa, N; Denno, R; Fujimoto, M; Hirata, AK; Ishibiki, K; Ishihara, R; Ishikawa, S; Iwai, S; Kinoshita, H; Koide, H; Kunimatsu, M; Manabe, T; Mashita, K; Mizuno, A; Morimoto, K; Mukaiya, M; Ohnishi, H; Ohtsuka, K; Sakaguchi, S; Shinagawa, N; Takuma, K; Tanimura, H; Umemoto, Y; Ushijima, Y; Yura, J | 1 |
| Takazakura, E; Tsuji, H | 1 |
| Inoue, Y; Maeda, N; Sato, S; Shimomura, Y; Tano, Y; Watanabe, H | 1 |
| Edelstein, PH | 1 |
| Edlund, C; Nord, CE; Sabouri, S | 1 |
| Ho, SW; Hsueh, PR; Jan, IS; Luh, KT; Teng, LJ | 1 |
| Igari, J; Nakamura, A; Oguri, T; Tabe, Y | 1 |
| Akiyama, H; Arata, J; Kanzaki, H; Tada, J; Yamasaki, O | 1 |
| Hikida, M; Igarashi, A; Itahashi, K; Kitamura, M; Shiba, T | 1 |
| Arita, K; Daido, K; Kohara, T; Nakamura, K; Ohashi, N; Takeshima, Y | 1 |
| Geddes, A; Härkönen, M; Jacobs, F; Nowotny, I; Schonwald, S; Thaler, M | 1 |
| Barberán, J; Borja, J; García-Barbal, J; Gomis, M; Khorrami, S; Sánchez, B | 1 |
| Fridkin, SK; Gaynes, RP; Hubert, SK; Lawton, R; McGowan, JE; Steward, CD; Tenover, FC; Wallace, D | 1 |
| Bryskier, A; Carbon, C; Farinotti, R; Joly-Guillou, ML; Wolff, M | 1 |
| Hashido, H; Ishigo, S; Iwata, I; Matsubara, S; Matsukawa, Y; Mikamo, H; Sawamura, H; Suematsu, H; Tamaya, T | 1 |
| Hostacká, A | 1 |
| Calvo, A; García, R; Gómez-Lus, ML; Leturia, A; Sevillano, D; Valero, E | 1 |
| Harada, H; Iwasaki, Y; Minagawa, T; Nagata, K; Nakagawa, M; Nakanishi, M; Natsuhara, A; Takemura, Y | 1 |
| Karasawa, T; Kuriyama, T; Nakagawa, K; Nakamura, S; Yamamoto, E | 1 |
| Kern, WV; Marre, R; Perner, S; Rentschler, J; Sing, A; Wellinghausen, N | 1 |
| Furugo, I; Ishida, M; Takii, M; Ueda, M | 1 |
| Erdem, I; Goktas, P; Kaya, B; Kaynar-Tascioglu, J | 1 |
| Estève, E; Georgescu, V; Lespessailles, E; Martin, L; Poisson, DM | 1 |
| Boulanger, BR; Fogarty, C; Fowler, C; Kahn, JB; Morgan, N; Oross, M; Tennenberg, A; West, M; Wiesinger, B; Wu, SC | 1 |
| Hata, K; Hisamori, S; Inoue, T; Ishimaru, H; Katoh, K; Maeda, Y; Maniwa, K; Minaguchi, M; Oida, K; Sakuramoto, M; Taguchi, Y; Tanaka, E; Terada, K | 1 |
| Shiotani, J; Takehana, K | 1 |
| Burgess, DS; Frei, CR; Moczygemba, LR | 1 |
| Coker, A; Coker, C; Erkan, N; Onek, T; Sağol, O; Zeytunlu, M | 1 |
| Benbrika, S; Boukari, L; Fain, O; Kettaneh, A; Letellier, E; Stirnemann, J; Thomas, M | 1 |
| Lister, PD; Wolter, DJ | 1 |
| Kollef, MH; Shorr, AF; Susla, GB | 1 |
| Jackson, WL; Kollef, MH; Ramage, AS; Shorr, AF; Tennenberg, AM; Wu, SC; Zadeikis, N | 1 |
| Engel, AE; Glass, D; Li, C; Wexler, HM | 1 |
| Berlutti, F; Scazzocchio, F; Selan, L; Tarantino, U; Thaller, MC | 1 |
| Lister, PD; Reisbig, MD; Wickman, PA; Wolter, DJ | 1 |
| Gómez Gómez, J; López Fornás, F; Lorente Salinas, I; Martínez García, F; Pérez Salmerón, J; Roldán Conesa, D; Ruiz Gómez, J; Segovia Hernández, M; Valdés Chávarri, M | 1 |
| Appelbaum, PC; Clark, CL; Ednie, LM; Kosowska-Shick, K | 1 |
| Guo, ZL; He, LX; He, ZG; Liang, YJ; Ren, T; Zhai, XB; Zhang, L; Zheng, YH | 1 |
| Dowzicky, M; Kuti, JL; Nicolau, DP | 1 |
| Memmi, M; Messadi, AA; Thabet, L; Turki, A | 1 |
| Cox, JC; Drachman, DA; Hibbard, ML; Kopelman, TR; Maly, TJ; Matthews, MR; O'Neill, PJ; Quan, AN; Vail, SJ | 1 |
| Araj, GF; Awar, GN; Baban, TA; Kanj, SS; Naba, MR; Tabbarah, ZA | 1 |
| Eden, A; Le Falher, G; Le Moing, V; Lesnik, A; Makinson, A; Reynes, J | 1 |
| Altboum, Z; Kobiler, D; Levy, H; Ophir, Y; Pass, A; Rothschild, N; Schlomovitz, J; Tal, A; Weiss, S | 1 |
| Fukuchi, K; Gomi, K; Takahashi, N; Wakuta, R; Yamaguchi, F | 1 |
| Kim, JS; Kim, NY; Lee, KJ; Park, JS; Yun, HK | 1 |
| Goto, H; Higaki, M; Honda, K; Ishii, H; Mikura, S; Nakamura, M; Okazaki, M; Tsunoda, T; Wada, H; Watanabe, T; Yasutake, T | 1 |
| Kan, Y; Kartal, M; Orhan, IE; Ozcelik, B | 1 |
| Kaniga, K; Lee, M; Redman, R; Rice, DA | 1 |
| Debata, NK; Jena, J; Sahoo, RK; Subudhi, E | 1 |
| Fernandes, M; Kumar, N; Medikonda, R; Vira, D | 1 |
| Ahmad, I; Akhtar, T; Ambreen, A; Gandapor, AJ; Khan, A; Khan, AM; Ullah, O | 1 |
| Debata, NK; Gaur, M; Jena, J; Sahoo, RK; Subudhi, E | 1 |
| Abdelwahab, SI; Dafalla, OME; Homeida, HE; Taha, MME | 1 |
| Adeleye, AI; Ajayi, A; Akinpelu, S; Smith, SI | 1 |
3 review(s) available for ofloxacin and imipenem, anhydrous
| Article | Year |
|---|---|
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
New antibiotics: areas of appropriate use.
Topics: Anti-Bacterial Agents; Aztreonam; Bacterial Infections; beta-Lactamase Inhibitors; Cephalosporins; Ciprofloxacin; Enoxacin; Humans; Imipenem; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Thienamycins | 1987 |
Quinolones for treatment of nosocomial pneumonia: a meta-analysis.
Topics: Anti-Infective Agents; Cilastatin; Ciprofloxacin; Cross Infection; Humans; Imipenem; Levofloxacin; Meta-Analysis as Topic; Ofloxacin; Pneumonia, Bacterial; Quinolones; Randomized Controlled Trials as Topic | 2005 |
9 trial(s) available for ofloxacin and imipenem, anhydrous
| Article | Year |
|---|---|
[Can various antibiotics be combined for treating salpingitis?].
Topics: Doxycycline; Drug Combinations; Female; Humans; Imipenem; Ofloxacin; Salpingitis | 1992 |
Clinical and bacteriological efficacy, and practical aspects of amikacin given once daily for severe infections.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Cefotaxime; Ceftazidime; Cross Infection; Drug Administration Schedule; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Male; Middle Aged; Ofloxacin; Piperacillin; Prospective Studies | 1991 |
Prospective randomized clinical trials of new quinolones versus beta-lactam antibiotics in lower respiratory tract infections.
Topics: Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Clavulanic Acids; Drug Combinations; Drug Therapy, Combination; Humans; Imipenem; Ofloxacin; Pneumonia; Prospective Studies; Remission Induction; Respiratory Tract Infections; Sepsis; Ticarcillin | 1990 |
Susceptibility of bacterial isolates from complicated skin and skin structure infections to cefazolin, imipenem-cilastatin, ciprofloxacin and ofloxacin.
Topics: Adolescent; Adult; Anti-Infective Agents; Bacteria; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Ofloxacin; Skin Diseases, Bacterial; Soft Tissue Infections | 1995 |
Levofloxacin in the empirical treatment of patients with suspected bacteraemia/sepsis: comparison with imipenem/cilastatin in an open, randomized trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteremia; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Levofloxacin; Middle Aged; Ofloxacin; Protease Inhibitors; Sepsis; Thienamycins | 1999 |
Oral ofloxacin versus parenteral imipenem-cilastatin in the treatment of osteomyelitis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Chronic Disease; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Injections, Intravenous; Male; Middle Aged; Ofloxacin; Osteomyelitis; Prospective Studies | 1999 |
Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: a multicenter, prospective, randomized, open-label study.
Topics: Adult; Aged; Anti-Bacterial Agents; Cilastatin; Ciprofloxacin; Cross Infection; Drug Therapy, Combination; Female; Humans; Imipenem; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Prospective Studies; Pseudomonas aeruginosa | 2003 |
Levofloxacin for treatment of ventilator-associated pneumonia: a subgroup analysis from a randomized trial.
Topics: Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Cohort Studies; Cross Infection; Double-Blind Method; Drug Combinations; Drug Resistance, Bacterial; Female; Humans; Imipenem; Levofloxacin; Male; Middle Aged; Multivariate Analysis; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Thienamycins; Treatment Outcome; Ventilators, Mechanical | 2005 |
Activity of doripenem versus comparators in subjects with baseline bacteraemia in six pooled phase 3 clinical trials.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Female; Humans; Imipenem; Intraabdominal Infections; Male; Meropenem; Ofloxacin; Pneumonia; Thienamycins; Treatment Outcome; Urinary Tract Infections | 2013 |
82 other study(ies) available for ofloxacin and imipenem, anhydrous
| Article | Year |
|---|---|
rpoN gene of Pseudomonas aeruginosa alters its susceptibility to quinolones and carbapenems.
Topics: Carbapenems; Gene Expression Regulation, Bacterial; Genes, Bacterial; Promoter Regions, Genetic; Pseudomonas aeruginosa; Quinolones; RNA Polymerase Sigma 54; Transcription, Genetic; Virulence | 2007 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Identification and phenotypic characterization of a beta-lactam-dependent, methicillin-resistant Staphylococcus aureus strain.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Cephalosporins; Chromosomes, Bacterial; DNA-Binding Proteins; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression Regulation, Bacterial; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Sequence Data; Oligonucleotide Array Sequence Analysis; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Selection, Genetic; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Staphylococcus aureus; Transcription, Genetic | 2007 |
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Chromosomes, Bacterial; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Integrons; Molecular Epidemiology; Molecular Sequence Data; Mutation; Plasmids; Polymerase Chain Reaction; Porins; Pseudomonas aeruginosa; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Spain | 2007 |
Methicillin-resistant Staphylococcus saprophyticus isolates carrying staphylococcal cassette chromosome mec have emerged in urogenital tract infections.
Topics: Bacterial Proteins; Chromosomes, Bacterial; Electrophoresis, Gel, Pulsed-Field; Methicillin Resistance; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus; Urinary Tract Infections | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
Macrolide antibiotic-mediated downregulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Outer Membrane Proteins; Down-Regulation; Humans; Macrolides; Membrane Transport Proteins; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Quorum Sensing | 2008 |
Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation.
Topics: Base Sequence; beta-Lactam Resistance; Carbapenems; DNA Primers; DNA, Bacterial; Doripenem; Fluoroquinolones; Genes, Bacterial; Humans; In Vitro Techniques; Meropenem; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 2008 |
AAC(6')-Iaf, a novel aminoglycoside 6'-N-acetyltransferase from multidrug-resistant Pseudomonas aeruginosa clinical isolates.
Topics: Acetylation; Acetyltransferases; Aminoglycosides; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Integrons; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2009 |
First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate.
Topics: Acinetobacter baumannii; beta-Lactamases; DNA, Bacterial; Escherichia coli; France; Genes, Bacterial; Water Microbiology | 2010 |
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Synthesis and antimycobacterial activity of imidazo[1,2-b][1,2,4,5]tetrazines.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Erythromycin; Heterocyclic Compounds, 2-Ring; Imidazoles; Imipenem; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium smegmatis; Mycobacterium tuberculosis; Ofloxacin; Protein Serine-Threonine Kinases; Rifampin | 2019 |
Synthesis and evaluation of 1,3,4-oxadiazole derivatives for development as broad-spectrum antibiotics.
Topics: Anti-Bacterial Agents; Cell Line, Tumor; Cell Survival; Drug Design; Drug Synergism; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Oxadiazoles | 2019 |
[Three cases of postpartum infection with methicillin-resistant Staphylococcus aureus (MRSA)].
Topics: Adult; Cefmetazole; Drug Therapy, Combination; Female; Humans; Imipenem; Methicillin Resistance; Minocycline; Ofloxacin; Puerperal Infection; Scarlet Fever; Staphylococcal Infections | 1992 |
Ofloxacin and imipenem in the treatment of Mycobacterium fortuitum and Mycobacterium chelonae lung infections.
Topics: Adult; Female; Humans; Imipenem; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Ofloxacin; Tuberculosis, Pulmonary | 1990 |
In vitro activity of PD 117596-2, a broad-spectrum difluoroquinolone.
Topics: Anti-Infective Agents; Bacteria; Ceftazidime; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins; Imipenem; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas; Staphylococcus; Streptococcus | 1989 |
Streptococcus faecalis: in vitro susceptibility to antimicrobial drugs, single and combined, with and without defibrinated human blood.
Topics: Animals; Anti-Bacterial Agents; Blood; Cattle; Enterococcus faecalis; Fibrin; Fusidic Acid; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Ofloxacin; Oxazines; Penicillins; Rabbits; Thienamycins; Vancomycin | 1986 |
In vitro activity of temafloxacin, a new difluoro quinolone antimicrobial agent.
Topics: Anti-Bacterial Agents; Cefotaxime; Chemical Phenomena; Chemistry; Ciprofloxacin; Culture Media; Drug Resistance, Microbial; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Hydrogen-Ion Concentration; Imipenem; Magnesium; Ofloxacin; Oxazines; Pseudomonas; Quinolines; Quinolones; Thienamycins | 1988 |
In vitro antibacterial activity of imipenem in combination with newer quinolone derivatives.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Evaluation, Preclinical; Drug Interactions; Drug Resistance, Microbial; Humans; Imipenem; Norfloxacin; Ofloxacin; Oxazines; Thienamycins | 1988 |
Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969).
Topics: Anti-Bacterial Agents; Bacteria; Ceftazidime; Ciprofloxacin; Fluoroquinolones; Gentamicins; Humans; Imipenem; Naphthyridines; Ofloxacin; Oxazines; Thienamycins | 1988 |
In vitro antibacterial activities of PD 138312 and PD 140248, new fluoronaphthyridines with outstanding gram-positive potency.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Gram-Positive Bacteria; Imipenem; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Topoisomerase II Inhibitors | 1993 |
The treatment of irradiated mice with polymicrobial infection caused by Bacteroides fragilis and Escherichia coli.
Topics: Abscess; Animals; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Feces; Female; Imipenem; Immunocompromised Host; Liver; Metronidazole; Mice; Microbial Sensitivity Tests; Ofloxacin; Whole-Body Irradiation | 1994 |
[Susceptibility to antibiotics and biochemical activity of strains of Acinetobacter sp. isolated from various sources].
Topics: Acinetobacter; Animals; Ciprofloxacin; Drug Resistance, Microbial; Environmental Microbiology; Humans; Imipenem; Netilmicin; Ofloxacin; Patients' Rooms; Soil Microbiology; Species Specificity; Water Microbiology | 1993 |
The incidence of isolation of methicillin-resistant Staphylococcus aureus (MRSA) strains from skin infections during the past three years (1989-1991).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteriophage Typing; Child; Cilastatin; Coagulase; Colony Count, Microbial; Drug Resistance, Microbial; Humans; Imipenem; Impetigo; Methicillin Resistance; Middle Aged; Minocycline; Ofloxacin; Pressure Ulcer; Staphylococcal Skin Infections; Staphylococcus aureus | 1993 |
Comparison of activities of trovafloxacin (CP-99,219) and five other agents against 585 anaerobes with use of three media.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Ciprofloxacin; Clindamycin; Culture Media; Drug Resistance, Microbial; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Imipenem; In Vitro Techniques; Metronidazole; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin | 1996 |
Pharmacodynamic effects of antibiotics and antibiotic combinations on growing and nongrowing Staphylococcus epidermidis cells.
Topics: Amikacin; Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Imipenem; Microbial Sensitivity Tests; Ofloxacin; Rifampin; Staphylococcus epidermidis; Vancomycin | 1997 |
In vitro efficacy of levofloxacin alone or in combination tested against multi-resistant Pseudomonas aeruginosa strains.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Ceftazidime; Ciprofloxacin; Drug Resistance, Multiple; Gentamicins; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Piperacillin; Pseudomonas aeruginosa; Tobramycin | 1996 |
Therapeutic effects of cefozopran against experimental mixed urinary tract infection with Enterococcus faecalis and Pseudomonas aeruginosa in mice.
Topics: Ampicillin; Animals; Cefozopran; Ceftazidime; Cephalosporins; Cilastatin; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Imipenem; Mice; Mice, Inbred CBA; Ofloxacin; Pseudomonas Infections; Urinary Tract Infections | 1997 |
Imipenem and cephem resistant Pseudomonas aeruginosa carrying plasmids coding for class B beta-lactamase.
Topics: Anti-Infective Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporinase; Hydrolysis; Imipenem; Isoelectric Focusing; Microbial Sensitivity Tests; Ofloxacin; Plasmids; Porins; Pseudomonas aeruginosa; Thienamycins | 1996 |
[Isolation rate of Enterococcus spp. from surgical infections and their susceptibilities].
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Microbial; Enterococcus; Humans; Imipenem; Levofloxacin; Ofloxacin; Penicillins; Surgical Wound Infection; Thienamycins; Time Factors; Vancomycin | 1997 |
[Legionella pneumonia successfully treated despite late diagnosis].
Topics: Administration, Oral; Aged; Anti-Infective Agents; Cilastatin; Drug Combinations; Humans; Imipenem; Legionnaires' Disease; Levofloxacin; Male; Ofloxacin; Protease Inhibitors; Thienamycins | 1997 |
Bilateral corneal infection as a complication of laser in situ keratomileusis.
Topics: Adolescent; Cilastatin; Cornea; Corneal Diseases; Corneal Transplantation; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Imipenem; Injections, Intravenous; Laser Therapy; Male; Ofloxacin; Ointments; Ophthalmic Solutions; Protease Inhibitors; Staphylococcal Infections; Staphylococcus aureus | 1997 |
Legionnaires' disease.
Topics: Anti-Infective Agents; Azithromycin; Humans; Imipenem; Legionnaires' Disease; Ofloxacin | 1998 |
Comparative in vitro activity of BAY 12-8039 and five other antimicrobial agents against anaerobic bacteria.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Anaerobic; Cefoxitin; Cephamycins; Clindamycin; Fluoroquinolones; Imipenem; Metronidazole; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; Thienamycins | 1998 |
Antimicrobial susceptibility testing for Klebsiella pneumoniae isolates resistant to extended-spectrum beta-lactam antibiotics.
Topics: Anti-Infective Agents; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Ciprofloxacin; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Monobactams; Ofloxacin; Thienamycins | 1998 |
Molecular characterization of epidemic multiresistant Staphylococcus haemolyticus isolates.
Topics: Ampicillin; Anti-Bacterial Agents; Cefazolin; Cefmetazole; Cross Infection; DNA Restriction Enzymes; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Gentamicins; Hospital Bed Capacity, 500 and over; Humans; Imipenem; Infant, Newborn; Microbial Sensitivity Tests; Neonatal Nursing; Nursing Staff, Hospital; Ofloxacin; Oxacillin; Phylogeny; Staphylococcal Infections; Staphylococcus; Tobramycin; Vancomycin | 1998 |
Streptococci isolated from various skin lesions: the interaction with Staphylococcus aureus strains.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Erythromycin; Fluoroquinolones; Fusidic Acid; Humans; Imipenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillins; Skin Diseases, Bacterial; Species Specificity; Streptococcal Infections; Streptococcus; Vancomycin | 1999 |
In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activity.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Carrier Proteins; Cefdinir; Cephalosporins; Dipeptidases; Drug Stability; Escherichia coli Proteins; Hexosyltransferases; Imipenem; Lactams; Levofloxacin; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Ofloxacin; Penicillin-Binding Proteins; Peptidoglycan Glycosyltransferase; Peptidyl Transferases; Protein Binding; Serine-Type D-Ala-D-Ala Carboxypeptidase; Thienamycins | 1999 |
[Study on antibiotics susceptibility and mechanism of carbapenem-resistance in clinical isolates of Pseudomonas aeruginosa].
Topics: Anti-Infective Agents; beta-Lactam Resistance; Carbapenems; Ceftazidime; Cephalosporins; Imipenem; Meropenem; Ofloxacin; Pseudomonas aeruginosa; Thienamycins | 1999 |
Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of project ICARE laboratories.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Enterococcus faecium; Erythromycin; Humans; Imipenem; Laboratories, Hospital; Meropenem; Ofloxacin; Oxacillin; Penicillins; Pseudomonas aeruginosa; Reproducibility of Results; Serratia marcescens; Staphylococcus aureus; Streptococcus pneumoniae; Thienamycins; Vancomycin | 2000 |
In vivo activity of levofloxacin alone or in combination with imipenem or amikacin in a mouse model of Acinetobacter baumannii pneumonia.
Topics: Acinetobacter Infections; Amikacin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Area Under Curve; Disease Models, Animal; Drug Therapy, Combination; Female; Imipenem; Levofloxacin; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Ofloxacin; Pneumonia, Bacterial; Thienamycins | 2000 |
[The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefixime; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Imipenem; Japan; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillin G; Penicillins; Streptococcus pneumoniae; Thienamycins | 2000 |
The in vitro effect of imipenem and ofloxacin on enzymic activity of Klebsiella strains.
Topics: Anti-Infective Agents; Humans; Imipenem; Klebsiella; Klebsiella Infections; Lipase; Microbial Sensitivity Tests; Ofloxacin; Thienamycins; Urease | 2000 |
[Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii].
Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Infective Agents; Aza Compounds; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Moxifloxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Opportunistic Infections; Quinolines; Sulbactam; Thienamycins | 2001 |
[Mycobacterium abscessus infection complicated with diabetes mellitus].
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Diabetes Complications; Drug Combinations; Drug Therapy, Combination; Humans; Imipenem; Levofloxacin; Male; Mycobacterium Infections, Nontuberculous; Ofloxacin; Tuberculosis, Pulmonary | 2002 |
Bacteriology and antimicrobial susceptibility of gram-positive cocci isolated from pus specimens of orofacial odontogenic infections.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cefazolin; Cefotaxime; Cephalosporins; Clindamycin; Corynebacterium; Drug Resistance, Bacterial; Erythromycin; Eubacterium; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Imipenem; Levofloxacin; Ofloxacin; Penicillins; Peptostreptococcus; Periodontitis; Staphylococcus; Streptococcus; Sulbactam; Thienamycins; Tooth Diseases | 2002 |
A fatal case of necrotizing sinusitis due to toxigenic Corynebacterium ulcerans.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Corynebacterium; Corynebacterium Infections; Diphtheria Toxin; Fatal Outcome; Humans; Imipenem; Male; Maxillary Sinusitis; Necrosis; Ofloxacin; Peptide Fragments | 2002 |
[Microbiological and clinical studies of Haemophilus influenzae isolated at Kitakyushu Municipal Medical Center from 1996 through 1999].
Topics: Adult; Aged; Ampicillin; Anti-Infective Agents; beta-Lactamases; Cefaclor; Cephalosporins; Child, Preschool; Female; Haemophilus influenzae; Humans; Imipenem; Infant; Infant, Newborn; Levofloxacin; Male; Meningitis, Bacterial; Meropenem; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Respiratory System; Seasons; Sulbactam; Thienamycins | 2002 |
The comparison of in the vitro effect of imipenem or meropenem combined with ciprofloxacin or levofloxacin against multidrug-resistant Pseudomonas aeruginosa strains.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Imipenem; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 2002 |
[Digital purpura revealing septicaemical rat-bite fever].
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Arthritis, Infectious; Diagnosis, Differential; Female; Fingers; Humans; Imipenem; Ofloxacin; Purpura; Rat-Bite Fever; Sepsis; Streptobacillus; Treatment Outcome | 2002 |
[A case of pulmonaly bulla infection with Mycobacterium fortuitum].
Topics: Aged; Blister; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Levofloxacin; Lung Diseases, Interstitial; Minocycline; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Ofloxacin; Pulmonary Emphysema | 2003 |
[Sensitivity of MRSA isolated in our hospital to various antibacterial agents: changes over 5 years].
Topics: Aminoglycosides; Coagulase; Dibekacin; Drug Resistance, Bacterial; Enterotoxins; Humans; Imipenem; Methicillin Resistance; Netilmicin; Ofloxacin; Staphylococcus aureus; Teicoplanin; Vancomycin | 2004 |
Pharmacodynamic modeling of carbapenems and fluoroquinolones against bacteria that produce extended-spectrum beta-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Ciprofloxacin; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Klebsiella pneumoniae; Lactams; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Ofloxacin; Thienamycins | 2004 |
Effects of selected antibiotics on pancreatitis induced liver and pulmonary injury.
Topics: Acute Disease; Alanine Transaminase; Amylases; Animals; Anti-Bacterial Agents; Aspartate Aminotransferases; Imipenem; L-Lactate Dehydrogenase; Levofloxacin; Liver; Liver Diseases; Lung; Lung Diseases; Male; Nitric Oxide; Ofloxacin; Pancreatitis; Rats; Rats, Wistar | 2005 |
[A case of yersiniasis with multiple liver abscesses].
Topics: Diabetes Mellitus, Type 1; Drug Therapy, Combination; Hemochromatosis; Hepatitis; Humans; Imipenem; Liver Abscess; Male; Middle Aged; Ofloxacin; Radiography, Abdominal; Time Factors; Tomography, X-Ray Computed; Yersinia enterocolitica; Yersinia Infections | 2005 |
Levofloxacin-imipenem combination prevents the emergence of resistance among clinical isolates of Pseudomonas aeruginosa.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections | 2005 |
In vitro activities of doripenem and comparator agents against 364 anaerobic clinical isolates.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactams; Carbapenems; Doripenem; Ertapenem; Humans; Imipenem; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Thienamycins | 2005 |
Antibiotic susceptibility of slime-producing isolates from orthopedic patients.
Topics: Anti-Bacterial Agents; Cefotaxime; Clindamycin; Colony-Forming Units Assay; Humans; Imipenem; Microbial Sensitivity Tests; Miocamycin; Myxococcales; Ofloxacin; Orthopedic Procedures; Postoperative Complications | 1989 |
Levofloxacin/imipenem prevents the emergence of high-level resistance among Pseudomonas aeruginosa strains already lacking susceptibility to one or both drugs.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Synergism; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa | 2006 |
[Comparative study of treatment with quinupristin-dalfopristin alone or in combination with gentamicin, teicoplanin, imipenem or levofloxacin in experimental endocarditis due to a multidrug-resistant Enterococcus faecium].
Topics: Aged; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Rabbits; Teicoplanin; Virginiamycin | 2006 |
Capability of 11 antipneumococcal antibiotics to select for resistance by multistep and single-step methodologies.
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Clarithromycin; Clavulanic Acid; Clindamycin; Drug Resistance, Bacterial; Fluoroquinolones; Gemifloxacin; Imipenem; Ketolides; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Streptococcus pneumoniae | 2007 |
Research and clinical value of antibacterial-application software.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Imipenem; Isosorbide Dinitrate; Male; Ofloxacin; Software | 2008 |
A pharmacodynamic simulation to assess tigecycline efficacy for hospital-acquired pneumonia compared with other common intravenous antibiotics.
Topics: Anti-Bacterial Agents; Cross Infection; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Models, Biological; Monte Carlo Method; Ofloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Tigecycline | 2008 |
The impact of fluoroquinolones use on antibiotic resistance in an intensive care burn department.
Topics: Acinetobacter; Anti-Infective Agents; Burn Units; Ceftazidime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Klebsiella pneumoniae; Ofloxacin; Pseudomonas aeruginosa | 2010 |
Empiric, broad-spectrum antibiotic therapy with an aggressive de-escalation strategy does not induce gram-negative pathogen resistance in ventilator-associated pneumonia.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pneumonia, Ventilator-Associated; Retrospective Studies; Tobramycin | 2010 |
Emergence of fluoroquinolone-resistant Streptococcus pneumoniae in Lebanon: a report of three cases.
Topics: Aged; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Clarithromycin; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Lebanon; Levofloxacin; Male; Ofloxacin; Pneumococcal Infections; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Vancomycin | 2010 |
[Two cases of pulmonary gangrene in HIV-infected patients: favorable outcome without surgery].
Topics: Acetamides; Adult; Alcoholism; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Gangrene; Gentamicins; HIV Infections; Humans; Imipenem; Linezolid; Lung; Male; Metronidazole; Necrosis; Ofloxacin; Oxazolidinones; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Smoking; Tomography, X-Ray Computed | 2011 |
Antibiotics cure anthrax in animal models.
Topics: Animals; Anthrax; Anthrax Vaccines; Anti-Bacterial Agents; Antigens, Bacterial; Bacillus anthracis; Bacteremia; Doxycycline; Enzyme-Linked Immunosorbent Assay; Gentamicins; Guinea Pigs; Imipenem; Ofloxacin; Rabbits | 2011 |
[Validity of using imipenem as a representative carbapenems and levofloxacin as a representative fluoroquinolones in antibiotics susceptibility test for enterobacteriaceae].
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Fluoroquinolones; Imipenem; Levofloxacin; Ofloxacin | 2011 |
[A case of acute phlegmonous gastritis causing gastroparesis and cured with medical treatment alone].
Topics: Acinetobacter; Acute Disease; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gastritis; Gastroparesis; Gastroscopy; Humans; Imipenem; Klebsiella oxytoca; Male; Ofloxacin; Pneumonia; Tomography, X-Ray Computed | 2011 |
Risk factors for bacteraemia attributable to Pseudomonas aeruginosa resistant to imipenem, levofloxacin, or gentamicin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Gentamicins; Humans; Imipenem; Infant; Infant, Newborn; Levofloxacin; Male; Middle Aged; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Young Adult | 2011 |
Inhibitory effects of various essential oils and individual components against extended-spectrum beta-lactamase (ESBL) produced by Klebsiella pneumoniae and their chemical compositions.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Food Preservatives; Gas Chromatography-Mass Spectrometry; Imipenem; Klebsiella pneumoniae; Lamiaceae; Mentha piperita; Microbial Sensitivity Tests; Ocimum basilicum; Ofloxacin; Oils, Volatile; Origanum; Plant Extracts; Satureja | 2011 |
Phylogenetic study of metallo-β-lactamase producing multidrug resistant Pseudomonas aeruginosa isolates from burn patients.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Burns; Ceftazidime; Ceftriaxone; Cilastatin; Clavulanic Acid; Colistin; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Resistance, Multiple, Bacterial; Genetic Variation; Humans; Imipenem; Minocycline; Netilmicin; Ofloxacin; Phylogeny; Polymerase Chain Reaction; Pseudomonas aeruginosa; Tigecycline | 2015 |
Extensively and pan-drug resistant Pseudomonas aeruginosa keratitis: clinical features, risk factors, and outcome.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Colistin; Corneal Ulcer; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Female; Humans; Imipenem; Keratoplasty, Penetrating; Male; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Visual Acuity | 2016 |
Antibiotic Sensitivity pattern of Bacterial Isolates of Neonatal Septicemia in Peshawar, Pakistan.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Enoxacin; Escherichia coli; Escherichia coli Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Infant, Low Birth Weight; Infant, Newborn; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Neonatal Sepsis; Ofloxacin; Pakistan; Proteus; Proteus Infections; Pseudomonas; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis | 2016 |
Genetic diversity study of various β-lactamase-producing multidrug-resistant
Topics: beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Colistin; DNA, Intergenic; Drug Resistance, Multiple, Bacterial; Escherichia coli; Genetic Variation; Humans; Imipenem; Microbial Sensitivity Tests; Ofloxacin; Polymerase Chain Reaction; Tertiary Care Centers | 2017 |
Multidrug resistance, prevalence and phylogenetic analysis of genes encoding class II and III integrons in clinically isolated Escherichia coli.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Base Sequence; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Expression Regulation, Bacterial; Gentamicins; Hospitals; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Nalidixic Acid; Ofloxacin; Phylogeny; Polymerase Chain Reaction; Prevalence; Saudi Arabia; Sequence Alignment | 2018 |
Efflux pump activity, biofilm formation and antibiotic resistance profile of Klebsiella spp. isolated from clinical samples at Lagos University Teaching Hospital.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Biofilms; Cefuroxime; Cells, Cultured; Community-Acquired Infections; Drug Combinations; Drug Resistance, Multiple, Bacterial; Hospitals, Teaching; Hospitals, University; Humans; Imipenem; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests; Nigeria; Ofloxacin; Tertiary Care Centers | 2020 |